Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for Qs to be asked about the GSA Press Release ..

Re: Time for Qs to be asked about the GSA Press Release ..

posted on Apr 24, 2009 09:40PM

"The SEC has long advocated an "equal access theory" with regard to 10b-5, arguing that anyone who has material, non-public information must either disclose that information or abstain from trading. "

Here is the catch-all. It was public knowledge, or information that crossflo had a GSA contract, since they were listed under certain goverment directories. Someone though took advantage of that loop-hole to make thousands of dollars of profit. The company seems to have participated in the scheme because they did not release information to us. Who knows how long that Crossflo had this GSA contract access? Was it before they merged with us? In either case, someone is being devious, or they are just inept.

This is just another example of the low regard that the company has had, or has with the retail shareholder and why the PPS is where it is today.

Share
New Message
Please login to post a reply